Proteomic approaches to predict bioavailability of fatty acids and their influence on cancer and chronic disease prevention

Journal of Nutrition

Volumn 142, Issue 7, 2012, Pages

  de Roos, Baukje ^a   Romagnolo, Donato F ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; ARGININOSUCCINATE SYNTHASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE III; CARBOXYLYASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYSTEINE SULFINATE DECARBOXYLASE; EPOXIDE HYDROLASE; FATTY ACID DERIVATIVE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; LINOLENIC ACID; MACROPHAGE INFLAMMATORY PROTEIN; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PEROXIREDOXIN 3; PHOSPHOPROTEIN PHOSPHATASE 2A; POLYUNSATURATED FATTY ACID; PROTEIN CDC42; SEPIAPTERIN REDUCTASE; TRANS FATTY ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ARTICLE; BIOAVAILABILITY; BIOINFORMATICS; BODY FLUID; BREAST CANCER; CANCER PREVENTION; CHRONIC DISEASE; COLORECTAL CANCER; FAT INTAKE; FISH; HUMAN; NONHUMAN; PLASMA; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RISK REDUCTION; STANDARDIZATION; URINE; VALIDATION PROCESS;

BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CHRONIC DISEASE; DIET; DIETARY FATS; FATTY ACIDS; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS;

EID: 84863550141     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.157206     Document Type: Article

References (62)

1. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:64-7.
2. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223-33.
3. Alexander DD, Cushing CA, Lowe KA, Sceurman B, Roberts MA. Meta-analysis of animal fat or animal protein intake and colorectal cancer. Am J Clin Nutr. 2009;89:1402-9.
4. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland R, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295: 403-15.
5. Saadatian-Elahi M, Norat T, Goudable J, Riboli E. Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer. 2004;111:584-91.
6. Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem Phys Lipids. 2008;153:14-23.
7. Aktas BH, Chorev M, Halperin JA. Cancer and n-3PUFAs: the translation initiation connection. In:Milner JA, Romagnolo DF, editors. Nutrition and health: bioactive compounds and cancer. New York: Springer Science; 2010. p. 253-73.
8. Forman MR, Mahabir S. Saturated fatty acids and cancer. In: Milner JA, Romagnolo DF, editors. Nutrition and health: bioactive compounds and cancer. New York: Springer Science; 2010. p. 213-33.
9. Lof M, Olivo-Marston S, Hilakivi-Clarke L. n-6 Polyunsaturated fatty acids and cancer. In: Milner JA, Romagnolo DF, editors. Nutrition and health: bioactive compounds and cancer. New York: Springer Science; 2010. p. 275-307.
10. Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, Hartman TJ, Manni A. Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res. 2011;71:6091-6.
11. Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res. 1997;57:3979-88.
12. Geelen A, Schouten JM, Kamphuis C, Stam BE, Burema J, Renkema JM, Bakker EJ, van't Veer P, Kampman E. Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol. 2007;166:1116-25.
13. Chavarro JE, Stampfer MJ, Hall MN, Sesso HD, Ma J. A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am J Clin Nutr. 2008;88:1297-303.
14. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348-80.
15. de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol. 2009;158:413-28.
16. de Roos B. Proteomic analysis of human plasma and blood cells in nutritional studies: development of biomarkers to aid disease prevention. Expert Rev Proteomics. 2008;5:819-26.
17. Zock PL, Katan MB. Linoleic acid intake and cancer risk: a review and meta-analysis. Am J Clin Nutr. 1998;68:142-53.
18. Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004;134: 919-22.
19. Simon JA, Chen YH, Bent S. The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr. 2009;89:S1558-64.
20. World Cancer Research Fund AICR. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 1st ed. Washington, DC: AICR; 2007.
21. Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, Clavel-Chapelon F, Thiébaut A, Chajès V, Key TJ, Allen NE, et al. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;119:175-82.
22. Kim J, Lim SY, Shin A, Sung MK, Ro J, Kang HS, Lee KS, Kim SW, Lee ES. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: acase-control study. BMC Cancer. 2009;9:216.
23. Kuriki K, Hirose K, Wakai K, Matsuo K, Ito H, Suzuki T, Hiraki A, Saito T, Iwata H, Tatematsu M, et al. Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese. Int J Cancer. 2007;121:377-85.
24. Hall MN, Chavarro JE, Lee IM, Willett WC, Ma J. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev. 2008;17:1136-43.
25. Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, Willett WC, Ma J. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16:314-21.
26. Dennis LK, Snetselaar LG, Smith BJ, Stewart RE, Robbins ME. Problems with the assessment of dietary fat in prostate cancer studies. Am J Epidemiol. 2004;160:436-44.
27. Harris WS. The omega-3 index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep. 2009;11:411-7.
28. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary longchain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935-45.
29. Hull MA. Omega-3 polyunsaturated fatty acids. Best Pract Res Clin Gastroenterol. 2011;25:547-54.
30. Vinolo MA, Hirabara SM, Curi R. G-protein-coupled receptors as fat sensors. Curr Opin Clin Nutr Metab Care. 2012;15:112-6.
31. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015-25.
32. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687-98.
33. Schwudke D, Schuhmann K, Herzog R, Bornstein SR, Shevchenko A. Shotgun lipidomics on high resolution mass spectrometers. Cold Spring Harb Perspect Biol. 2011;3:a004614.
34. Postle AD. Lipidomics. Curr Opin Clin Nutr Metab Care. 2012;15: 127-33.
35. de Roos B. Nutrition proteomics and biomarker discovery. Expert Rev Proteomics. 2009;6:349-51.
36. Arbones-Mainar JM, Ross K, Rucklidge GJ, Reid M, Duncan G, Arthur JR, Horgan GW, Navarro MA, Carnicer R, Carmen A, et al. Extra virgin olive oils increase hepatic fat accumulation and hepatic antioxidant protein levels in APOE(2/2) mice. J Proteome Res. 2007;6:4041-54.
37. de Roos B, Rucklidge G, Reid M, Ross K, Duncan G, Navarro MA, Arbones-Mainar JM, Guzman-Garcia MA, Osada J, Browne J, et al. Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipoprotein E knockout mice: a proteomics approach. FASEB J. 2005;19: 1746-8.
38. de Roos B, Duivenvoorden I, Rucklidge G, Reid M, Ross K, Lamers RJ, Voshol PJ, Havekes LM, Teusink B. Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data. FASEB J. 2005;19:813-5.
39. de Roos B, Geelen A, Ross K, Rucklidge G, Reid M, Duncan G, Caslake M, Horgan G, Brouwer IA. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics. 2008;8:1965-74.
40. de Roos B, Wanders AJ, Wood S, Horgan G, Rucklige G, Reid M, Siebelink E, Brouwer IA. A high intake of industrial or ruminant trans fatty acids does not affect the plasma proteome in healthy men. Proteomics. 2011;11:3928-34.
41. Mavrommatis Y, Ross K, Rucklidge G, Reid M, Duncan G, GordonMJ, Thies F, Sneddon A, de Roos B. Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice. Br J Nutr. 2010;103:16-24.
42. Rungapamestry V, McMonagle J, Rucklidge G, Reid M, Duncan G, Ross K, Horgan G, Toomey S, Moloney AP, Roos B, et al. Inter-organ proteomic analysis reveals insights into the molecular mechanisms underlying the anti-diabetic effects of cis-9, trans-11 conjugated linoleic acid in ob/ob mice. Proteomics. 2012;12:461-76.
43. Sidhu VK, Huang BX, Kim HY. Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)o/(18)o labeling. J Proteome Res. 2011;10:5472-80.
44. Santos-González M, Lopez-Miranda J, Perez-Jimenez F, Navas P, Villalba JM. Dietary oil modifies the plasma proteome during aging in the rat. Age (Dordr). 2012;34:341-58.
45. Cooney JM, Barnett MP, Brewster D, Knoch B, McNabb WC, Laing WA, Roy NC. Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated fatty acids with comparison to transcriptomic analysis. J Proteome Res. 2012;11:1065-77.
46. Knoch B, Barnett MP, Cooney J, McNabb WC, Barraclough D, Laing W, Roy NC. Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Biotechnol J. 2010;5:1226-40.
47. Zhong W, Jiang Z, Zheng C, Lin Y, Yang L, Zou S. Relationship between proteome changes of Longissimus muscle and intramuscular fat content in finishing pigs fed conjugated linoleic acid. Br J Nutr. 2011;105:1-9.
48. Novak EM, Lee EK, Innis SM, Keller BO. Identification of novel protein targets regulated by maternal dietary fatty acid composition in neonatal rat liver. J Proteomics. 2009;73:41-9.
49. Chang SI, El-Bayoumy K, Sinha I, Trushin N, Stanley B, Pittman B, Prokopczyk B. 4-(Methylnitrosamino)-I-(3-pyridyl)-1-butanone enhances the expression of apolipoprotein A-I and Clara cell 17-kDa protein in the lung proteomes of rats fed a corn oil diet but not a fish oil diet. Cancer Epidemiol Biomarkers Prev. 2007;16:228-35.
50. Chakravarty A. FDA. Surrogate markers: their role in regulatory decision process; 2003 [cited March 25, 2012]. Available from: http:// www.fda.gov/cder/Offices/Biostatistics/Chakravarty_376/sld016.htm.
51. Martins-de-Souza D. Is the word 'biomarker' being properly used by proteomics research in neuroscience? Eur Arch Psychiatry Clin Neurosci. 2010;260:561-2.
52. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1: 845-67.
53. Service RF. Proteomics. Will biomarkers take off at last? Science. 2008; 321:1760.
54. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res. 2001;51:637-46.
55. Shimizu M, Tamamori-Adachi M, Arai H, Tabuchi N, Tanaka H, Sunamori M. Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory kappaBalpha complex and attenuation of nuclear factor kappaB. J Thorac Cardiovasc Surg. 2002;124:933-41.
56. Ethridge RT, Hellmich MR, DuBois RN, Evers BM. Inhibition of heatshock protein 70 induction in intestinal cells overexpressing cyclooxygenase 2. Gastroenterology. 1998;115:1454-63.
57. Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med. 2010;3:33-40.
58. Delgoffe GM, Kole TP, Cotter RJ, Powell JD. Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Mol Immunol. 2009;46:2694-8.
59. Baccini M, Bachmaier EM, Biggeri A, Boekschoten MV, Bouwman FG, Brennan L, Caesar R, Cinti S, Coort SL, Crosley K, et al. The NuGO proof of principle study package: a collaborative research effort of the European Nutrigenomics Organisation. Genes Nutr. 2008;3:147-51.
60. de Roos B, Duthie SJ, Polley AC, Mulholland F, Bouwman FG, Heim C, Rucklidge GJ, Johnson IT, Mariman EC, Daniel H, et al. Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res. 2008;7:2280-90.
61. de Roos B, McArdle HJ. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. Br J Nutr. 2008;99:S66-71.
62. Rix U, Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat Chem Biol. 2009;5:616-24.